Skip to main content

Find Clinical Trials

Home
Conditions
Giant Cell Arteritis

Clinical trial condition

Giant Cell Arteritis

Explore clinical trials studying Giant Cell Arteritis. Study availability and eligibility vary by location and protocol.

72 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Giant Cell Arteritis trial results

Completed

Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers

NCT04885829

Conditions: Arteritis, Arthritis, Arthritis, Rheumatoid, +20 more
Locations: Nucleus Network, Brisbane Brisbane, Australia

Syngene International Ltd Bangalore, Karnataka, India

Auckland Clinical Studies Ltd (NZCR OpCo Limited) Grafton, Auckland, New Zealand

Christchurch Clinical Studies Trust Ltd (NZCR OpCo Limited) Christchurch, New Zealand

View Trial Details

Completed

Giant Cell Arteritis and Differential Diagnoses Associated With Positive Temporal Artery Biopsy

NCT04554290

Conditions: Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
Locations: Nancy University Hospital Nancy, Lorraine, France

View Trial Details

Completed

KPL-301 for Subjects With Giant Cell Arteritis

NCT03827018

Conditions: Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
Locations: Site 1703 Sarasota, Florida, United States

Site 1708 Tampa, Florida, United States

Site 1706 Atlanta, Georgia, United States

Site 1701 Boston, Massachusetts, United States

View all 49 locations

View Trial Details

Completed

Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA)

NCT03812302

Conditions: Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
Locations: University of Alberta Edmonton, Alberta, Canada

View Trial Details

Completed

A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis

NCT03765788

Conditions: Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
Locations: Novartis Investigative Site Berlin, Germany

Novartis Investigative Site Cologne, Germany

Novartis Investigative Site Dresden, Germany

Novartis Investigative Site Erlangen, Germany

View Trial Details

Completed

Prospective Follow-up Study of the Aortic Diameter in Patients With Giant Cell Arteritis

NCT01588483

Conditions: Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
Locations: University Hospital Leuven Leuven, Belgium

View Trial Details

Completed

Tocilizumab Plus a Short Prednisone Taper for GCA

NCT03726749

Conditions: Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Collection and Analysis of the Clinical and Biological Characteristics of Patients Treated for Giant Cells ARTEitis (Horton's Disease)

NCT04142515

Conditions: Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +14 more
Locations: CHUNimes Nîmes, France

View Trial Details

Completed

Assessment of Giant Cell Arteritis Medical Practices in France

NCT03658889

Conditions: Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
Locations: Hospital of the Archet Nice, Alpes-Maritimes, France

View Trial Details

Completed

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA).

NCT03923738

Conditions: Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
Locations: Universitätsspital Basel; Rheumatologie Basel, Switzerland

Inselspital Bern; Rheumatologie; Klinische Immunologie und Allergologie Bern, Switzerland

View Trial Details